{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:13:53Z","timestamp":1782926033190,"version":"3.54.5"},"reference-count":35,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Despite opioid prescribing for chronic non\u2010cancer pain (CNCP) having limited therapeutic benefits, recent evidence indicates significant increases in the prescribing of high\u2010strength opioids for individuals with CNCP. Patients prescribed opioids for CNCP have overdose risk factors but generally have low opioid overdose awareness and low perceptions of risk related to prescribed opioids. Currently, there are few bespoke overdose prevention resources for this group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This qualitative study investigated views on a naloxone intervention for people prescribed high\u2010strength opioids for CNCP delivered via community pharmacies. The intervention included overdose risk awareness and naloxone training and provision. Interviews were conducted with eight patients, four family members and two community pharmacists. Participants were convenience sampled and recruited through networks within the Scottish pain community. The Framework approach was used to analyse findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All participants had positive attitudes towards the intervention, but patients and family members considered risk of overdose to be very low. Three themes were identified: potential advantages of the intervention; potential barriers to the intervention; and additional suggestions and feedback about the intervention. Advantages included the intervention providing essential overdose information for CNCP patients. Barriers included resource and time pressures within community pharmacies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusion<\/jats:title><jats:p>While patients had low overdose knowledge and did not see themselves as being at risk of opioid overdose, they were receptive to naloxone use and positive about the proposed intervention. A feasibility trial is merited to further investigate how the intervention would be experienced within community pharmacy settings.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.13554","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T13:38:47Z","timestamp":1664285927000},"page":"517-526","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high\u2010strength opioids for chronic non\u2010cancer pain: An explorative intervention development study"],"prefix":"10.1111","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4536-5663","authenticated-orcid":false,"given":"Fiona","family":"Mercer","sequence":"first","affiliation":[{"name":"Salvation Army Centre for Addiction Services and Research, Faculty of Social Sciences University of Stirling  Stirling UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Parkes","sequence":"additional","affiliation":[{"name":"Salvation Army Centre for Addiction Services and Research, Faculty of Social Sciences University of Stirling  Stirling UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Foster","sequence":"additional","affiliation":[{"name":"Salvation Army Centre for Addiction Services and Research, Faculty of Social Sciences University of Stirling  Stirling UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Steven","sequence":"additional","affiliation":[{"name":"NHS Fife  Kirkcaldy UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McAuley","sequence":"additional","affiliation":[{"name":"School of Health and Life Sciences Glasgow Caledonian University  Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Baldacchino","sequence":"additional","affiliation":[{"name":"NHS Fife  Kirkcaldy UK"},{"name":"School of Medicine University of St Andrews  St Andrews UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wez","family":"Steele","sequence":"additional","affiliation":[{"name":"Freelance researcher  Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Schofield","sequence":"additional","affiliation":[{"name":"Salvation Army Centre for Addiction Services and Research, Faculty of Social Sciences University of Stirling  Stirling UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-1125","authenticated-orcid":false,"given":"Catriona","family":"Matheson","sequence":"additional","affiliation":[{"name":"Salvation Army Centre for Addiction Services and Research, Faculty of Social Sciences University of Stirling  Stirling UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"e_1_2_9_2_1","volume-title":"Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain","author":"The National Institute for Health and Care Excellence [NICE]","year":"2021"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.03.023"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcbs.2020.06.005"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002336"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18472"},{"key":"e_1_2_9_7_1","article-title":"Adverse events associated with medium\u2010and long\u2010term use of opioids for chronic non\u2010cancer pain: an overview of Cochrane reviews","volume":"10","author":"Els C","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnx021"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11162-4"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2022.101296"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1496"},{"key":"e_1_2_9_12_1","volume-title":"Drug\u2010related deaths in Scotland in 2020","author":"National Records of Scotland","year":"2021"},{"key":"e_1_2_9_13_1","volume-title":"Opioid overdose","author":"Schiller EY","year":"2017"},{"key":"e_1_2_9_14_1","volume-title":"Preventing opioid overdose deaths with take\u2010home naloxone","author":"European Monitoring Centre for Drugs and Drugs Addiction [EMCDDA]"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"e_1_2_9_16_1","volume-title":"Quality prescribing for chronic pain. A guide for improvement: 2018\u20132021","author":"Scottish Government and NHS Scotland","year":"2018"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.11.006"},{"key":"e_1_2_9_18_1","unstructured":"Scottish Drugs Forum (SDF).Lord advocate gives reassurance that naloxone supply can expand. 2020. Available from:https:\/\/www.sdf.org.uk\/lord-advocate-gives-reassurance-that-naloxone-supply-can-expand\/. Accessed 23 March 2022."},{"key":"e_1_2_9_19_1","unstructured":"U.S. Department of Health and Human Services.Pain management best practices. Interagency task force report: Updates gaps inconsistencies and recommendations. 2019."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3895-8"},{"key":"e_1_2_9_21_1","volume-title":"Overdose prevention information for people prescribed opioids for chronic pain: enhancing community pharmacists' capacity to respond","author":"Volpe I","year":"2020"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2021.2022100"},{"key":"e_1_2_9_23_1","unstructured":"National Institute for Health and Care Excellence.British National Formulary. 2020; Available from:https:\/\/bnf.nice.org.uk\/ Accessed 11 March 2022."},{"key":"e_1_2_9_24_1","volume-title":"Qualitative research practice: a guide for social science students and researchers","author":"Ritchie J","year":"2003"},{"key":"e_1_2_9_25_1","first-page":"56","article-title":"Overdose knowledge and perceptions of take\u2010home naloxone for patients with chronic non\u2010cancer pain","volume":"35","author":"Nielsen S","year":"2016","journal-title":"Drug Alcohol Rev"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2017.1296524"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01128.x"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2014.989352"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.03.011"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06577-5"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-7-6"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108346"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2010.08.035"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa190"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2017.1391924"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103061"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13554","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.13554","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.13554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T05:09:09Z","timestamp":1720760949000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.13554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1111\/dar.13554"],"URL":"https:\/\/doi.org\/10.1111\/dar.13554","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"2022-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}